Int J Pediatr Otorhinolaryngol:儿童前庭功能障碍的回顾性分析

2021-05-24 AlexYang MedSci原创

儿童眩晕使小儿前庭疾病的诊断复杂化,其表现形式也不清楚。眩晕和头晕在儿童中可表现为偏头痛、神经系统疾病、肠道疾病、眼科疾病或前庭病变。小儿眩晕在现代科学文献中首次由哈里森于1962年提及。由于听觉和前

儿童眩晕使小儿前庭疾病的诊断复杂化,其表现形式也不清楚。眩晕和头晕在儿童中可表现为偏头痛、神经系统疾病、肠道疾病、眼科疾病或前庭病变。小儿眩晕在现代科学文献中首次由哈里森于1962年提及。由于听觉和前庭病变的同时存在,新生儿听力筛查项目广泛的普及提高了人们对小儿前庭病变的认识。在美国,每年每1000个出生的婴儿中,有2到3个有听力障碍,其中20%-70%有前庭障碍。

近期,有研究人员阐述了儿童中最常见的前庭障碍及其在前庭功能测试中的相关结果

研究人员在3400名进行前庭评估的患者中收集了203名儿童的数据,这些患者在一家三级医院的眩晕中心接受了3年的前庭评估。儿童的平均年龄为11.16±3.87(范围,1-17)岁,并对进行了回顾性的数据分析。

结果发现,在3400名患者的203名儿童中,有78.3%(n=159)诊断为前庭障碍,表明他们研究队列的3年的发病率为4.67%。良性阵发性位置性眩晕(BPPV)是他们研究中儿童队列最常见的诊断(49%;n=100),其中包括原发性BPPV和与其他前庭病症相关的继发性BPPV。前庭偏头痛(VM)是第二大常见的诊断(41%;n=83),其次是儿童良性阵发性眩晕(BPVC;4.5%,n=9),前庭神经炎(VN;4.5%,n=9),和精神性眩晕(4.5%,n=9)。研究结果还显示,美尼尔病(MD;1.5%,n=3)和中枢性眩晕(1.5%,n=3)在儿童中较少诊断。只有1名儿童诊断为外淋巴瘘(PLF),并经手术证实。

159名前庭障碍儿童的诊断分布

综上所述,BPPV和VM是他们研究中最常见的小儿前庭疾病。临床医生应该了解最常见的儿童前庭疾病的发病率、体征和症状,以便于诊断、治疗和康复。另外,通过进行与年龄相适应的前庭功能测试,能够改善鉴别诊断,从而指导医学治疗和康复。

原始出处:

Ozlem Gedik-Soyuyuce, Zeynep Gence-Gumus , Alper Ozdilek et al. Vestibular disorders in children: A retrospective analysis of vestibular function test findings. Int J Pediatr Otorhinolaryngol. 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2021-07-22 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1728956, encodeId=5c151e28956c1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 22 17:24:15 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080497, encodeId=7e3e208049ea8, content=<a href='/topic/show?id=db063259162' target=_blank style='color:#2F92EE;'>#前庭功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32591, encryptionId=db063259162, topicName=前庭功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fe6351, createdName=flyingeagle77, createdTime=Fri Apr 08 05:24:15 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639768, encodeId=de501639e683d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Sep 22 21:24:15 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421367, encodeId=8936142136e67, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516787, encodeId=64ba1516e8795, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538332, encodeId=bf5d153833262, content=<a href='/topic/show?id=e1983258976' target=_blank style='color:#2F92EE;'>#前庭功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32589, encryptionId=e1983258976, topicName=前庭功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddff12959974, createdName=sjq031, createdTime=Wed May 26 05:24:15 CST 2021, time=2021-05-26, status=1, ipAttribution=)]

相关资讯

Nutrients:益生菌混合物用来预防儿童过敏性鼻炎症状

过敏性疾病在成人和儿童中越来越多。因其存在严重并发症的风险、导致生活质量低下和引起相关费用,因而它是一个公共卫生问题。据估计,超过20%的人口受过敏性疾病的影响,如过敏性鼻炎(AR)、哮喘、食物过敏和

Radiology:各位家长请注意,电子烟正在“吃掉”孩子的肺!

电子烟于2007年左右首次在美国推出,自2014年以来,电子烟已成为美国青少年最常用的烟草产品,且在过去几年里在青少年中的使用大幅增加。自2012起,在一些病例报告中开始提出有关使用电子烟与肺损伤之间

BMJ:是否应该为儿童接种抗SARS-CoV-2疫苗

是否应该为儿童接种抗SARS-CoV-2疫苗,对于大多数国家的大多数孩子来说,现在很难证明这是合理的。

JCEM:2006-2016年美国儿童糖尿病酮症酸中毒入院的全国趋势

美国儿童DKA入院率上升了40%,弱势群体风险最高。进一步的研究应归纳这些人群所面临的挑战,以为制定减轻其DKA风险的干预措施提供参考,并解决全国范围内DKA发生率上升的问题。

Int Arch Allergy Immunol:儿童的皮下过敏原免疫疗法:真实生活中的依从性和COVID-19大流行对其依从性的影响

皮下过敏原免疫疗法(SCIT)是治疗过敏性鼻炎、哮喘和毒液过敏的一种有效方法。由于是长期治疗,依从性对SCIT获得最大的益处至关重要。

BMJ:儿童新冠疫苗推广不应操之过急

covid-19儿童疫苗的广泛推出应遵循标准的监管程序,因为与成人不同,covid-19疫苗接种不是针对紧急情况。